64 related articles for article (PubMed ID: 22493387)
1. A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples.
Pelosi G; Melotti F; Cavazza A; Rossi G; Maisonneuve P; Graziano P; Barbareschi M; Nakatani Y; Papotti M
Anticancer Res; 2012 Apr; 32(4):1463-73. PubMed ID: 22493387
[TBL] [Abstract][Full Text] [Related]
2. Review article: pulmonary sarcomatoid carcinomas: a practical overview.
Pelosi G; Sonzogni A; De Pas T; Galetta D; Veronesi G; Spaggiari L; Manzotti M; Fumagalli C; Bresaola E; Nappi O; Viale G; Rosai J
Int J Surg Pathol; 2010 Apr; 18(2):103-20. PubMed ID: 19124452
[TBL] [Abstract][Full Text] [Related]
3. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
Spieler P; Gloor F
Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
[TBL] [Abstract][Full Text] [Related]
4. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G
J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
[TBL] [Abstract][Full Text] [Related]
6. An Epithelial-to-Mesenchymal Transcriptional Switch Triggers Evolution of Pulmonary Sarcomatoid Carcinoma (PSC) and Identifies Dasatinib as New Therapeutic Option.
Manzotti G; Torricelli F; Benedetta D; Lococo F; Sancisi V; Rossi G; Piana S; Ciarrocchi A
Clin Cancer Res; 2019 Apr; 25(7):2348-2360. PubMed ID: 30587547
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.
Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
Pathol Int; 2008 Feb; 58(2):75-83. PubMed ID: 18199156
[TBL] [Abstract][Full Text] [Related]
8. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
Uke M; Rekhi B; Ajit D; Jambhekar NA
Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
[TBL] [Abstract][Full Text] [Related]
9. Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer.
Shintani Y; Okimura A; Sato K; Nakagiri T; Kadota Y; Inoue M; Sawabata N; Minami M; Ikeda N; Kawahara K; Matsumoto T; Matsuura N; Ohta M; Okumura M
Ann Thorac Surg; 2011 Nov; 92(5):1794-804; discussion 1804. PubMed ID: 22051275
[TBL] [Abstract][Full Text] [Related]
10. p63 immunostaining in destained bronchoscopic cytological specimens.
Shtilbans V; Szporn AH; Wu M; Burstein DE
Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in non-small cell lung carcinomas.
Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
[TBL] [Abstract][Full Text] [Related]
12. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Mukhopadhyay S; Katzenstein AL
Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
[TBL] [Abstract][Full Text] [Related]
13. Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma.
Baldovini C; Rossi G; Ciarrocchi A
Lung Cancer (Auckl); 2019; 10():131-149. PubMed ID: 31824199
[TBL] [Abstract][Full Text] [Related]
14. p63 is useful in the diagnosis of mammary metaplastic carcinomas.
Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW
Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002
[TBL] [Abstract][Full Text] [Related]
15. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
Chang C; Wang P; Yang H; Li L; Zhang LB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
[TBL] [Abstract][Full Text] [Related]
16. Value of demonstration of cytokeratin and leukocyte common antigen in poorly differentiated malignant tumors in fine needle aspirates.
Rajasekhar A; Kapila K; Verma K
Acta Cytol; 1989; 33(3):385-9. PubMed ID: 2471381
[TBL] [Abstract][Full Text] [Related]
17. Sarcomatoid carcinoma of the lung presenting as a cutaneous metastasis.
Terada T
J Cutan Pathol; 2010 Apr; 37(4):482-5. PubMed ID: 19602061
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
20. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
